You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Weight loss jabs do not slow Alzheimer's disease as hoped, causing firm's share prices to plummet ⊕

found 2025 › Nov › 24 (Mon) @ 19:30 UTC

a story from The Daily Mail 💩 › The Daily Mail

Weight ■■
Alzheimer ■■■
Novo ■■
Nordisk ■■
Ozempic ■■

Novo Nordisk had hoped to repurpose semaglutide - the active ingredient in its Wegovy and Ozempic jabs - as a groundbreaking dementia treatment after seeing early encouraging signs.